A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.

Saved in:
Bibliographic Details
Title: A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer.
Authors: Gurule NJ; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., McCoach CE; Department of Medicine and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA., Hinz TK; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Merrick DT; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Van Bokhoven A; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Kim J; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Patil T; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Calhoun J; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Nemenoff RA; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Tan AC; Moffitt Cancer Center, Tampa, FL, USA., Doebele RC; Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Robert.Doebele@cuanschutz.edu., Heasley LE; Department of Craniofacial Biology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. Lynn.Heasley@cuanschutz.edu.; Eastern Colorado VA Healthcare System, Rocky Mountain Regional VA Medical Center, Aurora, CO, USA. Lynn.Heasley@cuanschutz.edu.
Source: NPJ precision oncology [NPJ Precis Oncol] 2021 May 17; Vol. 5 (1), pp. 41. Date of Electronic Publication: 2021 May 17.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2397-768X
DOI:10.1038/s41698-021-00181-4